Skip to main content

Samvat 2078 : Predictions



After a stellar liquidity-driven run in Samvat 2077, experts are suggesting that investors should brace for a volatile phase for Indian equity markets in Samvat 2078. The market direction, they say, will be guided by a host of domestic and foreign factors that will keep the markets choppy. These include:


  • Commodity prices and their impact on inflation and corporate earnings
  • Policy stance of global central banks, especially the US Federal Reserve
  • A fresh wave of Covid infections, if any
  • Global developments like economic recovery and China factors
  • IPO pipeline and liquidity with retail investors


While rising input prices, especially those of crude oil and coal, have seen the markets trim gains in the past few weeks, analysts at Nomura have penciled in 0.6-0.7% rise in inflation over the next few months as a result of this.


Sonal Varma, chief economist for India and Asia ex-Japan, Nomura, said: “We estimate the impact on headline inflation to be as much as around 1 percentage point over the course of the next six months”


As an investment strategy for Samvat 2078, instead of chasing index-wide returns, experts suggest investors look for companies with sound fundamentals, low debt levels and revenue and profit visibility, given the multiple headwinds.

Rupen Rajguru, Head of Equity Investments and Strategy, Julius Baer, for instance, expects the frontline indices to give a high single-digit to a mid-double-digit return in the next one year.


According to Rajguru:

  • High single-digit to mid-double-digit return
  • Underperformers will try to catch up
  • Economy-facing sectors should do well
  • Capex cycle recovery will be a theme to bet on
  • Bullish on healthcare, large-cap IT, specialty chemicals


Dhananjay Sinha, managing director & chief strategist at JM Financial sees the Nifty between 16,500 and 18,500 levels going ahead.

According to Krishna Kumar Karwa, managing director at Emkay Global, ample domestic liquidity will keep market sentiment buoyant, despite headwinds.

Global liquidity, however, could be at risk as the US Fed starts to taper. He said:

Not many investment alternatives for investors due to low interest rates

Liquidity will flow depending on available opportunities

Tech-led IPOs will get investor’s interest


So, while gains at the index level may not be significant in the upcoming Samvat, investors should brace for a volatile phase in equities now, with good financial and operational performance by corporates getting suitably rewarded at the bourses, despite headwinds.


Talking of the market drivers for this holiday-curtailed week, all eyes will be on Manufacturing and Services PMI data for India and the monthly auto sales figures, the outcome of the US Federal Reserve meeting for cues on when the central bank plans to hike rates. On Thursday, the exchanges will hold a special Muhurat Trading session in the evening to usher in Samvat 2078. Bharti Airtel, SBI, HDFC, IRCTC, Tata Motors and HPCL are some of the prominent companies that are scheduled to announce their September quarter results this week.

(source: Business Standard)

Labels:

Comments

Post a Comment

Popular posts from this blog

The Asian Paints Price Hike Stroke

This paint business, which was once a stock market favourite, hasn't had a fantastic year. While the Sensex has increased by more than 50%, Asian Paints has only increased by 30%. The Synopsis Asian Paints, the world's largest paint manufacturer, has raised prices by just 3% a year for the past 20 years. That's correct, despite the fact that we've had to cope with out-of-control inflation everywhere, paint costs have never been an issue. The corporation, on the other hand, has finally rolled up its sleeves and is getting down to work. Asian Paints, the industry leader, is raising prices by 7–10 percent starting November 12th. Yes, it's advising everyone to spruce up their homes before Diwali. But, you may wonder, why the abrupt change of heart. Of sure, earnings are important. Sales increased by 32% year over year, from Rs 5,350 crores to almost Rs 7,000 crores, according to the company's latest figures (July-September). However, its net income dropped by 28%, f...
Post a Comment
Read more

Pharm Easy: A Mini Portfolio

  Indian Digital healthcare platform Pharm Easy became the latest startup business in our country and listed in domestic market. Pharm Easy provide health service ranging from tele-communication to radiology test and provide home delivery of medical products.   When we compare the past 3months sales of the company, now the monitary value of sales of the company stood at 30.26 billion Rupees. Pharmacy’s company may consider a private issuance of shares worth up to 12.50 billion rupees. Naspers, a technology-focused investor, as well as organizations connected with global investment group CDPQ and private equity firm TPG, are among the company's investors. The company acquired thyrocare technologies, India's leading diagnostic test provider, in order to diversify its operations. The IPO filing for pharmeasy comes on the same day as Nykaa, an Indian fashion         e-commerce firm, is scheduled to debut on the stock exchange, and Paytm, a finance...
Post a Comment
Read more